|
C6ORF186 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.6941565058396E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27050000023432E-07 |
| Normal-vs-Stage2 |
9.28900000252142E-08 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.439800E-01 |
| Stage1-vs-Stage3 |
9.003600E-02 |
| Stage1-vs-Stage4 |
2.747900E-02 |
| Stage2-vs-Stage3 |
9.056400E-02 |
| Stage2-vs-Stage4 |
2.671800E-02 |
| Stage3-vs-Stage4 |
3.950200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2335022720199E-11 |
| Normal-vs-AfricanAmerican |
6.180200E-01 |
| Normal-vs-Asian |
1.62547753035369E-12 |
| Caucasian-vs-AfricanAmerican |
2.969600E-01 |
| Caucasian-vs-Asian |
2.626400E-01 |
| AfricanAmerican-vs-Asian |
2.042400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
3.05130032351997E-10 |
| Male-vs-Female |
3.402800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.239920E-04 |
| Normal-vs-Age(41-60Yrs) |
4.01723099230367E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6251444634463E-12 |
| Normal-vs-Age(81-100Yrs) |
1.06059999671615E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.035200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.637400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.086350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.017600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.405600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.194990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.581730E-04 |
| Classical-VS-Follicular |
4.634200E-02 |
| Classical-VS-Other |
6.053400E-01 |
| Classical-VS-Normal |
2.24986695940288E-12 |
| Tall-VS-Follicular |
4.44010000000272E-05 |
| Tall-VS-Other |
3.652200E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
8.942000E-01 |
| Follicular-VS-Normal |
5.262400E-03 |
| Other-VS-Normal |
6.044400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47660000000094E-05 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.520010E-03 |
|
|
